Russian Chemical Reviews
RUS  ENG    JOURNALS   PEOPLE   ORGANISATIONS   CONFERENCES   SEMINARS   VIDEO LIBRARY   PACKAGE AMSBIB  
General information
Latest issue
Archive
Impact factor
Guidelines for authors

Search papers
Search references

RSS
Latest issue
Current issues
Archive issues
What is RSS


Usp. Khim.:
Year:
Volume:
Issue:
Page:
Find




Personal entry:
Login:
Password:
Save password
Enter
Forgotten password?
Register

Russian Chemical Reviews, 2018, Volume 87, Issue 6, Pages 509–552
DOI: https://doi.org/10.1070/RCR4791 (Mi rcr4211) 		 
This article is cited in 12 scientific papers (total in 12 papers)

Arbidol: a quarter-century later. Past, present and future of the original Russian antiviral

Konstantin V. Balakinab, Rosanna Filosacde, Sergey N. Lavrenovf, Arthur S. Mkrtchyang, Maxim B. Nawrozkijg, Ivan A. Novakovg

a Kazan (Volga Region) Federal University
b I. M. Sechenov First Moscow State Medical University
c Department of Experimental Medicine, Section of Biotechnology, University of Campania "Luigi Vanvitelli", Italy
d Consorzio Sannio Tech, Italy
e Institute of Food Sciences, National Research Council, Italy
f Gause Institute of New Antibiotics, Moscow
g Volgograd State Technical University
English full-text Citations (12)
DOI: https://doi.org/10.1070/RCR4791
Abstract: The present review relates to the synthesis and structure-activity relationship studies of Arbidol and its structural analogues. The latter are roughly divided into several unequal parts: indole- and benzofuran-based compounds, benzimidazole and imidazopyridine bioisosteres, and ring-expanded quinoline derivatives. Much attention is focused on various types of antiviral activity of the above-mentioned Arbidol congeners, as well as of the parent compound itself. Features of Arbidol synthesis and metabolic changes are also discussed.
Bibliography — 166 references.
Funding agency Grant number
Russian Foundation for Basic Research 16-33-6003 mol_a_dk
Ministry of Education and Science of the Russian Federation
Received: 18.10.2017
Russian version:
Uspekhi Khimii, 2018, Volume 87, Issue 6, Pages 509–552
DOI: https://doi.org/10.1070/RCR4791
Bibliographic databases:
Document Type: Article
Language: English
Original paper language: English
Citation: Konstantin V. Balakin, Rosanna Filosa, Sergey N. Lavrenov, Arthur S. Mkrtchyan, Maxim B. Nawrozkij, Ivan A. Novakov, “Arbidol: a quarter-century later. Past, present and future of the original Russian antiviral”, Usp. Khim., 87:6 (2018), 509–552; Russian Chem. Reviews, 87:6 (2018), 509–552
Citation in format AMSBIB
\Bibitem{BalFilLav18}
\by Konstantin~V.~Balakin, Rosanna~Filosa, Sergey~N.~Lavrenov, Arthur~S.~Mkrtchyan, Maxim~B.~Nawrozkij, Ivan~A.~Novakov
\paper Arbidol: a quarter-century later. Past, present and future of the original Russian antiviral
\jour Usp. Khim.
\yr 2018
\vol 87
\issue 6
\pages 509--552
\mathnet{http://mi.mathnet.ru/rcr4211}
\crossref{https://doi.org/10.1070/RCR4791}
\adsnasa{https://adsabs.harvard.edu/cgi-bin/bib_query?2018RuCRv..87..509B}
\elib{https://elibrary.ru/item.asp?id=34973239}
\transl
\jour Russian Chem. Reviews
\yr 2018
\vol 87
\issue 6
\pages 509--552
\crossref{https://doi.org/10.1070/RCR4791}
\isi{https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=000437806900001}
\scopus{https://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85048057986}
Linking options:
  • https://www.mathnet.ru/eng/rcr4211
  • https://doi.org/10.1070/RCR4791
  • https://www.mathnet.ru/eng/rcr/v87/i6/p509
    • This publication is cited in the following 12 articles:
    Citing articles in Google Scholar: Russian citations, English citations
    Related articles in Google Scholar: Russian articles, English articles
    		Успехи химии Russian Chemical Reviews
    Statistics & downloads:
    Abstract page:192
     
      Contact us:
    		  Terms of Use  Registration to the website  Logotypes © Steklov Mathematical Institute RAS, 2024